Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma

BSE219.503.35 (+1.55 %)

PREV CLOSE ( ) 216.15

OPEN PRICE ( ) 217.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6165

TODAY'S LOW / HIGH ( )216.35 223.75

52 WK LOW / HIGH ( )178.1 474

NSE219.202.9 (+1.34 %)

PREV CLOSE( ) 216.30

OPEN PRICE ( ) 217.25

BID PRICE (QTY) 219.20 (638)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 126895

TODAY'S LOW / HIGH( ) 216.80 221.00

52 WK LOW / HIGH ( )178.8 472.8

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-03 2006

Management Info

Dilip S Shanghvi - Chairman - Managing Director

Registered Office

Address Plot No.5 & 6/1, Savli G. I. D. C. Estate,Savli - Vadodara Highway,Manjusar ,
Vadodara,
Gujarat-391775

Phone 0265- 2330815

Email secretarial@sparcmail.com

Website www.sparc.life

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, MCX

NEWS

10Apr Sun Pharma Advanced Research Company i
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

10Apr Sun Pharma Advanced Research Company i
Sun Pharma Advanced Research Company has confirmed that activities in re..

07Mar Sun Pharma Advanced Research Company i
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

04Jan Sun Pharma Advanced Research Company i
Sun Pharma Advanced Research Company has confirmed that the Company is i..

06Nov Sun Pharma Advanced Research Company i
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	-996.5	-2225.8
Gross Profit	-996.5	-2225.8
Operating Profit	-962.3	-2031.8
Net Sales	138.6	2387.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Just Dial (BSE) 998.40 (2.48%)	M.Cap ( in Cr)8490.42
Evans Electric (BSE) 382.00 (4.99%)	M.Cap ( in Cr)104.82
Majestic Auto (BSE) 338.40 (3.12%)	M.Cap ( in Cr)351.85
Dynavision (BSE) 330.00 (2.63%)	M.Cap ( in Cr)126.72
Latent View Analytic (BSE) 489.45 (1.49%)	M.Cap ( in Cr)10082.56

Shareholding Pattern

	PROMOTERS	65.67%
	NON-INSTITUTION	30.42%
	MUTUAL FUNDS/UTI	0.25%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ITI Pharma & Health...	1.35
Motilal Oswal S&P B...	0.27
HDFC NIFTY Smallcap...	0.19
Nippon India Nifty ...	0.19
Edelweiss Nifty Sma...	0.19
ICICI Pru Nifty Sma...	0.19
Motilal Oswal Nifty...	0.19

Risk Disclosures on Derivatives

Smart Quotes

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.